Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis.

Pickering RJ, Tikellis C, Rosado CJ, Tsorotes D, Dimitropoulos A, Smith M, Huet O, Seeber RM, Abhayawardana R, Johnstone EK, Golledge J, Wang Y, Jandeleit-Dahm KA, Cooper ME, Pfleger KD, Thomas MC.

J Clin Invest. 2019 Jan 2;129(1):406-421. doi: 10.1172/JCI99987. Epub 2018 Dec 10.

2.

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors.

Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F.

Kidney Int. 2002 Jun;61(6):1986-95.

3.

Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.

Esteban V, Ruperez M, Sánchez-López E, Rodríguez-Vita J, Lorenzo O, Demaegdt H, Vanderheyden P, Egido J, Ruiz-Ortega M.

Circ Res. 2005 May 13;96(9):965-73. Epub 2005 Apr 14.

PMID:
15831814
4.

Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.

Ihara Y, Egashira K, Nakano K, Ohtani K, Kubo M, Koga J, Iwai M, Horiuchi M, Gang Z, Yamagishi S, Sunagawa K.

J Mol Cell Cardiol. 2007 Oct;43(4):455-64. Epub 2007 Jul 21.

PMID:
17761193
5.

A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.

Balakumar P, Jagadeesh G.

Cell Signal. 2014 Oct;26(10):2147-60. doi: 10.1016/j.cellsig.2014.06.011. Epub 2014 Jul 5. Review.

PMID:
25007996
6.

Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.

Rüster C, Bondeva T, Franke S, Tanaka N, Yamamoto H, Wolf G.

Am J Nephrol. 2009;29(6):538-50. doi: 10.1159/000191467. Epub 2009 Jan 8.

PMID:
19129693
7.

sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.

Lim S, Lee ME, Jeong J, Lee J, Cho S, Seo M, Park S.

Inflamm Res. 2018 Aug;67(8):691-701. doi: 10.1007/s00011-018-1160-9. Epub 2018 May 23.

PMID:
29796842
8.

Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.

Shah BH, Yesilkaya A, Olivares-Reyes JA, Chen HD, Hunyady L, Catt KJ.

Mol Endocrinol. 2004 Aug;18(8):2035-48. Epub 2004 May 13.

PMID:
15143154
10.

Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.

Belmokhtar K, Robert T, Ortillon J, Braconnier A, Vuiblet V, Boulagnon-Rombi C, Diebold MD, Pietrement C, Schmidt AM, Rieu P, Touré F.

Arterioscler Thromb Vasc Biol. 2016 May;36(5):800-9. doi: 10.1161/ATVBAHA.115.306349. Epub 2016 Mar 17.

PMID:
26988587
12.

The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IkappaB kinase complex.

Douillette A, Bibeau-Poirier A, Gravel SP, Clément JF, Chénard V, Moreau P, Servant MJ.

J Biol Chem. 2006 May 12;281(19):13275-84. Epub 2006 Mar 2.

13.

Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.

Galandrin S, Denis C, Boularan C, Marie J, M'Kadmi C, Pilette C, Dubroca C, Nicaise Y, Seguelas MH, N'Guyen D, Banères JL, Pathak A, Sénard JM, Galés C.

Hypertension. 2016 Dec;68(6):1365-1374. Epub 2016 Oct 3.

PMID:
27698068
14.

Angiotensin II, via angiotensin receptor type 1/nuclear factor-κB activation, causes a synergistic effect on interleukin-1-β-induced inflammatory responses in cultured mesangial cells.

Alique M, Sánchez-López E, Rayego-Mateos S, Egido J, Ortiz A, Ruiz-Ortega M.

J Renin Angiotensin Aldosterone Syst. 2015 Mar;16(1):23-32. doi: 10.1177/1470320314551564. Epub 2014 Oct 29.

15.
16.

Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells.

Pollreisz A, Hudson BI, Chang JS, Qu W, Cheng B, Papapanou PN, Schmidt AM, Lalla E.

Atherosclerosis. 2010 Oct;212(2):451-6. doi: 10.1016/j.atherosclerosis.2010.07.011. Epub 2010 Jul 21.

17.
18.

A disintegrin and metalloproteinase 17 (ADAM17) mediates epidermal growth factor receptor transactivation by angiotensin II on hepatic stellate cells.

Oikawa H, Maesawa C, Tatemichi Y, Nishinari Y, Nishiya M, Mizugai H, Ikeda A, Oikawa K, Takikawa Y, Masuda T.

Life Sci. 2014 Mar 3;97(2):137-44. doi: 10.1016/j.lfs.2013.12.028. Epub 2014 Jan 8.

PMID:
24412389
19.

Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells.

Ji Y, Liu J, Wang Z, Liu N.

Cell Physiol Biochem. 2009;23(4-6):265-76. doi: 10.1159/000218173. Epub 2009 May 6.

20.

MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis functionality.

Pernomian L, do Prado AF, Gomes MS, Pernomian L, da Silva CH, Gerlach RF, de Oliveira AM.

Eur J Pharmacol. 2015 Oct 5;764:173-88. doi: 10.1016/j.ejphar.2015.07.007. Epub 2015 Jul 2.

PMID:
26144375

Supplemental Content

Support Center